Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23507
Title: Testosterone therapy considerations in estrogen, progesterone and androgen receptor positive breast cancer in a transgender male.
Austin Authors: Light, Melanie;McFarlane, Thomas;Ives, Andrew;Shah, Bhaumik;Lim, Elgene;Grossmann, Mathis ;Zajac, Jeffrey D ;Cheung, Ada S 
Affiliation: St Vincent's Clinical School, University of New South Wales, Darlinghurst, Sydney, Australia
Endocrinology
Aurora Specialists Care, Fitzroy, Australia
Masada Private Hospital, St Kilda East, Australia
Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia
Medicine (University of Melbourne)
Issue Date: Sep-2020
Date: 2020-06-10
Publication information: Clinical Endocrinology 2020; 93(3): 355-357
Abstract: A 44-year-old premenopausal individual assigned female at birth but with a male gender identity, presented requesting masculinizing hormone therapy for long-standing gender dysphoria. His past medical history was unremarkable, and being adopted, his family history was unknown. Baseline blood tests and hormonal panel were within female reference ranges (Table).
URI: https://ahro.austin.org.au/austinjspui/handle/1/23507
DOI: 10.1111/cen.14263
ORCID: 0000-0002-1213-6410
0000-0001-5257-5525
0000-0003-3933-5708
0000-0001-8261-3457
Journal: Clinical Endocrinology
PubMed URL: 32521051
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

50
checked on Dec 2, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.